Transitional Antibiotic Therapy
Author(s) -
Richard Quintiliani,
Helen M. Crowe,
Charles H. Nightingale
Publication year - 1995
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/1995/267316
Subject(s) - intensive care medicine , medicine , intravenous therapy , antibiotic therapy , bacteremia , health care , antibiotics , microbiology and biotechnology , economics , biology , economic growth
With all the fiscal restraints in healthcare systems. it is crucial to develop methods to treat infections that are both clinically sound and cost-effective. Of the various options available. the rapid transition from intravenous to oral therapy represents one of the most effective ways to attain these goals. Moreover, it has the further advantages of shortening hospital stay, reducing nosocomial bacteremia and avoiding the need to rely upon intravenous technicians and equipment. Although there is a need for more patient outcome studies with this approach, the early experience with transitional therapy appears promising
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom